WallStreetZenWallStreetZen

NASDAQ: PDEX
Pro Dex Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their PDEX stock forecasts and price targets.

Forecast return on equity

Is PDEX forecast to generate an efficient return?

Company
19.08%
Industry
17.3%
Market
329.64%
PDEX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PDEX forecast to generate an efficient return on assets?

Company
12.32%
Industry
12.72%
PDEX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PDEX earnings per share forecast

What is PDEX's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$2.43-29.22%
PDEX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PDEX revenue forecast

What is PDEX's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$71.4M+1.66%
PDEX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PDEX earnings growth forecast

How is PDEX forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
-29.22%
Industry
240.5%
Market
2,941.36%
PDEX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PDEX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PDEX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PDEX revenue growth forecast

How is PDEX forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
1.66%
Industry
5.03%
Market
1,452.31%
PDEX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PDEX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PDEX vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
PDEX$43.38N/AN/A
MBOT$2.41$8.75+263.07%Strong Buy
NYXH$4.73$9.00+90.27%Strong Buy
OSUR$2.49$3.00+20.48%Hold
UTMD$58.10N/AN/A
View Top Medical Stocks

Pro Dex Stock Forecast FAQ

What is PDEX's earnings growth forecast for 2026-2026?

(NASDAQ: PDEX) Pro Dex's forecast annual earnings growth rate of -29.22% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 240.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,941.36%.

Pro Dex's earnings in 2025 is $11,192,000.

In 2026, PDEX is forecast to generate $7,918,841 in earnings, with the lowest earnings forecast at $7,608,298 and the highest earnings forecast at $8,151,748.

If you're new to stock investing, here's how to buy Pro Dex stock.

What is PDEX's revenue growth forecast for 2026-2026?

(NASDAQ: PDEX) Pro Dex's forecast annual revenue growth rate of 1.66% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 5.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,452.31%.

Pro Dex's revenue in 2025 is $70,231,000.

In 2026, PDEX is forecast to generate $232,907,086 in revenue, with the lowest revenue forecast at $223,773,474 and the highest revenue forecast at $239,757,294.

What is PDEX's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: PDEX) forecast ROA is 12.32%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.72%.

What is PDEX's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: PDEX) Pro Dex's current Earnings Per Share (EPS) is $3.43. In 2026, PDEX's EPS is forecast to hit $2.43 (min: $2.33, max: $2.50).

What is PDEX's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: PDEX) forecast ROE is 19.08%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.